$6.40
0.488.11%
最終更新: Oct 20, 5:00 PM
$6.40
0.488.11%
Benzinga
Benzinga
Benzinga
水曜日, 10 21
Benzinga
© 2026 Benzinga | All Rights Reserved
Solid Biosciences (SLDB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.43 | $-0.52 | $-0.43 |
| Actual | $-0.38 | $-0.52 | $-0.53 | $-0.48 |
| Surprise | +17.4% | -20.9% | -1.92% | -11.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.40 | $-0.41 | $-0.38 | $-0.37 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.38 | $-0.46 | 17.4 % |
| Q1 | May 12, 2026 | $-0.52 | $-0.43 | -20.9 % |
| Q4 | Mar 19, 2026 | $-0.53 | $-0.52 | -1.92 % |
| Q3 | Nov 3, 2025 | $-0.48 | $-0.43 | -11.6 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2024 | $0 | $1.03M | -100.0 % |
| Q1 | May 15, 2024 | $0 | $1.21M | -100.0 % |
| Q4 | Mar 13, 2024 | $0 | $1.10M | -100.0 % |
| Q3 | Nov 8, 2023 | $0 | $1.10M | -100.0 % |